Clinical Trials Browser

Phase 2/3 × Nasopharyngeal Carcinoma × Drug Therapy × Clear all

NCT03344068 2017-12-22

Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma

Phase 2/3 Unknown

Nasopharyngeal Carcinoma